Skip to main content
Log in

Methotrexate restores HRQOL in juvenile rheumatoid arthritis

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Céspedes-Cruz A, Gutiérrez-Suárez R, Pistorio A, Ravelli A, Loy A, Murray KJ, Gerloni V, Wulffraat N, Oliveira S, Walsh J, Calvo Penades I, Alpigiani MG, Lahdenne P, Saad-Magalhães C, Cortis E, Lepore L, Kimura Y, Wouters C, Martini A, Ruperto N, Pediatric Rheumatology International Trials Organization (PRINTO).Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis. Annals of the Rheumatic Diseases 67: 309-314, No. 3, Mar 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Methotrexate restores HRQOL in juvenile rheumatoid arthritis. Pharmacoecon. Outcomes News 549, 10 (2008). https://doi.org/10.2165/00151234-200805490-00029

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805490-00029

Keywords

Navigation